1,580 Shares in CVS Health Co. (NYSE:CVS) Purchased by Capital Performance Advisors LLP

Capital Performance Advisors LLP purchased a new stake in CVS Health Co. (NYSE:CVS) during the third quarter, HoldingsChannel.com reports. The firm purchased 1,580 shares of the pharmacy operator’s stock, valued at approximately $99,000.

Several other large investors have also recently added to or reduced their stakes in the company. Pzena Investment Management LLC grew its position in CVS Health by 132.9% during the 2nd quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator’s stock worth $764,023,000 after acquiring an additional 7,382,931 shares during the last quarter. Capital International Investors grew its holdings in shares of CVS Health by 12.5% during the first quarter. Capital International Investors now owns 37,917,923 shares of the pharmacy operator’s stock worth $3,024,334,000 after purchasing an additional 4,226,225 shares during the last quarter. Capital World Investors increased its stake in shares of CVS Health by 8.0% in the first quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock valued at $3,491,643,000 after buying an additional 3,232,172 shares in the last quarter. Pathway Financial Advisers LLC lifted its position in CVS Health by 5,864.2% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,730,343 shares of the pharmacy operator’s stock worth $108,804,000 after buying an additional 1,701,331 shares in the last quarter. Finally, State of Michigan Retirement System grew its holdings in CVS Health by 402.5% during the 2nd quarter. State of Michigan Retirement System now owns 2,005,677 shares of the pharmacy operator’s stock worth $118,455,000 after acquiring an additional 1,606,500 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research analyst reports. Wells Fargo & Company dropped their target price on shares of CVS Health from $61.00 to $60.00 and set an “equal weight” rating for the company in a research note on Monday, November 4th. Evercore ISI increased their price objective on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research report on Tuesday, October 8th. Mizuho dropped their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Barclays decreased their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday. Finally, UBS Group boosted their price objective on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday. Nine investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $73.00.

CVS Health Price Performance

CVS opened at $55.56 on Friday. The company has a fifty day simple moving average of $59.56 and a 200 day simple moving average of $59.19. The company has a quick ratio of 0.66, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The stock has a market cap of $69.89 billion, a P/E ratio of 14.10, a P/E/G ratio of 0.94 and a beta of 0.55. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same quarter last year, the firm posted $2.21 earnings per share. CVS Health’s revenue was up 6.3% compared to the same quarter last year. On average, research analysts expect that CVS Health Co. will post 6.18 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.79%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio is 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.